From Proteome to Potential Drugs: Integration of Subtractive Proteomics and Ensemble Docking for Drug Repurposing against Pseudomonas aeruginosa RND Superfamily Proteins
Authors:
- Gabriela UrraGUGabriela Urra
- Elizabeth Valdés-MuñozEVElizabeth Valdés-Muñoz
- Reynier SuardiazReynier Suardiaz
- Erix W. Hernández-RodríguezErix W. Hernández-Rodríguez
- Jonathan M. PalmaJPJonathan M. Palma
- Sofía E. Ríos-RozasSRSofía E. Ríos-Rozas
- Camila A. Flores-MoralesCFCamila A. Flores-Morales
- Melissa Alegría-ArcosMAMelissa Alegría-Arcos
- Osvaldo YáñezOYOsvaldo Yáñez
- Luis Morales-QuintanaLuis Morales-Quintana
- Vívian D’afonsecaVDVívian D’afonseca
- Daniel BustosDBDaniel Bustos
Open Access
- 23 July 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (15) , 8027
Abstract
Pseudomonas aeruginosa (P. aeruginosa) poses a significant threat as a nosocomial pathogen due to its robust resistance mechanisms and virulence factors. This study integrates subtractive proteomics and ensemble docking to identify and characterize essential proteins in P. aeruginosa, aiming to discover therapeutic targets and repurpose commercial existing drugs. Using subtractive proteomics, we refined the dataset to discard redundant proteins and minimize potential cross-interactions with human proteins and the microbiome proteins. We identified 12 key proteins, including a histidine kinase and members of the RND efflux pump family, known for their roles in antibiotic resistance, virulence, and antigenicity. Predictive modeling of the three-dimensional structures of these RND proteins and subsequent molecular ensemble-docking simulations led to the identification of MK-3207, R-428, and Suramin as promising inhibitor candidates. These compounds demonstrated high binding affinities and effective inhibition across multiple metrics. Further refinement using non-covalent interaction index methods provided deeper insights into the electronic effects in protein–ligand interactions, with Suramin exhibiting superior binding energies, suggesting its broad-spectrum inhibitory potential. Our findings confirm the critical role of RND efflux pumps in antibiotic resistance and suggest that MK-3207, R-428, and Suramin could be effectively repurposed to target these proteins. This approach highlights the potential of drug repurposing as a viable strategy to combat P. aeruginosa infections.Keywords
Funding Information
- ANID Fondecyt de Iniciación en Investigación (#11220444, FOVI230136, R19-3409, R20-6912, R21-6448709305, PID2020-113147GA-I00, PID2021-122839NB-I00, #ATE220014, #11230033, #3170107, #11201049, #1241305)
- Royal Society of Chemistry (#11220444, FOVI230136, R19-3409, R20-6912, R21-6448709305, PID2020-113147GA-I00, PID2021-122839NB-I00, #ATE220014, #11230033, #3170107, #11201049, #1241305)
- MCIN/AEI/10.13039/501100011033 (#11220444, FOVI230136, R19-3409, R20-6912, R21-6448709305, PID2020-113147GA-I00, PID2021-122839NB-I00, #ATE220014, #11230033, #3170107, #11201049, #1241305)
- Anillo (#11220444, FOVI230136, R19-3409, R20-6912, R21-6448709305, PID2020-113147GA-I00, PID2021-122839NB-I00, #ATE220014, #11230033, #3170107, #11201049, #1241305)
- ANID Fondecyt de Iniciación en Investigación (#11220444, FOVI230136, R19-3409, R20-6912, R21-6448709305, PID2020-113147GA-I00, PID2021-122839NB-I00, #ATE220014, #11230033, #3170107, #11201049, #1241305)
- ANID FONDECYT de Postdoctorado (#11220444, FOVI230136, R19-3409, R20-6912, R21-6448709305, PID2020-113147GA-I00, PID2021-122839NB-I00, #ATE220014, #11230033, #3170107, #11201049, #1241305)
- ANID Fondecyt Iniciación en Investigación (#11220444, FOVI230136, R19-3409, R20-6912, R21-6448709305, PID2020-113147GA-I00, PID2021-122839NB-I00, #ATE220014, #11230033, #3170107, #11201049, #1241305)
- ANID FONDECYT REGULAR (#11220444, FOVI230136, R19-3409, R20-6912, R21-6448709305, PID2020-113147GA-I00, PID2021-122839NB-I00, #ATE220014, #11230033, #3170107, #11201049, #1241305)
This publication has 79 references indexed in Scilit:
- Small proteins in bacteria – Big challenges in prediction and identificationProteomics, 2023
- Pseudomonas aeruginosa biofilms and their partners in crimeBiotechnology Advances, 2021
- The Bio3D packages for structural bioinformaticsProtein Science, 2020
- Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agentsInternational Journal of Clinical Pharmacy, 2020
- Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017JAMA, 2020
- Suramin blocks interaction between human FGF1 and FGFR2 D2 domain and reduces downstream signaling activityBiochemical and Biophysical Research Communications, 2016
- Crystal structures of OprN and OprJ, outer membrane factors of multidrug tripartite efflux pumps of Pseudomonas aeruginosaProteins: Structure, Function, and Bioinformatics, 2016
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Alignment and structure prediction of divergent protein families: periplasmic and outer membrane proteins of bacterial efflux pumpsJournal of Molecular Biology, 1999
- Suramin in the treatment of AIDS: Mechanism of actionAntiviral Research, 1987